HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,977,560 | +88.9% | 34,755 | +31.3% | 0.04% | +77.3% |
| Q3 2022 | $1,047,000 | +408.3% | 26,471 | +466.0% | 0.02% | +450.0% |
| Q2 2022 | $206,000 | -1.0% | 4,677 | -10.2% | 0.00% | +33.3% |
| Q1 2022 | $208,000 | -80.1% | 5,208 | -77.3% | 0.00% | -82.4% |
| Q3 2021 | $1,044,000 | 0.0% | 22,986 | 0.0% | 0.02% | +21.4% |
| Q2 2021 | $1,044,000 | +43.8% | 22,986 | +32.0% | 0.01% | +27.3% |
| Q1 2021 | $726,000 | +14420.0% | 17,413 | +5685.0% | 0.01% | – |
| Q4 2019 | $5,000 | – | 301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |